Incyte Corporation (INCY) is a Wilmington, Delaware-based biopharmaceutical company founded in 2002 that discovers, develops, and commercializes proprietary medicines for oncology, inflammation, autoimmunity, and dermatology; it operates gl…
HQ: Wilmington, DE, United States of Americawww.incyte.com
USD121.47-1.47%vs prev. close
Market snapshot
Price
USD121.47
Daily move
-1.47%
P/E
15.7
EPS TTM
7.74
Dividend yield
—
Beta
0.77
Market cap
24.6B
Price history
INCY price
USD
No price history available
Next earnings
No upcoming earnings report scheduled in the next 6 months.
Peer comparison
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Incyte
INCY
Biotechnology
24.6
15.7
—
-4.2%
+0.6%
+11.9%
+31.3%
+41.0%
+23.0%
🔒
Subscribe to Equity Analytics to compare INCY with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.